FUJIFILM Diosynth Biotechnologies
About the organisation
FUJIFILM Diosynth Biotechnologies is a world leading contract development and manufacturing organization with expertise in biologics, vaccines, cell and gene therapies, partnering with today’s most innovative biopharmaceutical companies on life-altering medicines.
FUJIFILM Diosynth Biotechnologies operates a global network with locations in the Unites States of America, the United Kingdom and Denmark. The company is building a new manufacturing site in Holly Springs, North Carolina, USA – the largest end-to-end cell culture CDMO site in North America.
United by our mission of advancing tomorrow’s medicine, we are a global community of over 4000 – and growing. As FUJIFILM Diosynth Biotechnologies continues to grow and build its global footprint, we are uniquely positioned to provide long-term support to our customers across a full range of modalities, process complexities and manufacturing scales.
4000 employees - and growing
4 Technologies: Microbial, Mammalian, Cell & Gene Therapy and Viral Vaccines
19 licenses for commercial manufacturing
$7.4 Billion invested in recent years
